Summary

Canine Orthopedics Market Growth & Trends

The global canine orthopedics market size is estimated to reach USD 661.82 million by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Some of the drivers attributing to the market growth include rising pet dog ownership, the number of veterinary surgeries across the globe, initiatives by key companies, and orthopedic disorders in pet dogs. In February 2022, the MedTech segment of Vimian Group-Movora acquired IMEX Veterinary, Inc-a veterinary orthopedic implants supplier in the U.S. This complemented the company’s portfolio and enabled Movora to enter a new niche segment within surgical products. Post-acquisition, IMEX became the 4th company in the Movora family of brands that include Veterinary Orthopedic Implants, KYON AG, and BioMedtrix, LLC.

The COVID-19 pandemic led to a decrease in revenue for market players in the market. This was due to cancellation or delay in elective surgical procedures during 2020. Other challenges faced by key companies included logistical bottlenecks and dampened demand. The market, however, recovered gradually to pre-COVID numbers during 2021. In addition, the COVID-19 pandemic has catalyzed pet ownership according to findings of the Pet Food Manufacturers Association (PFMA), U.K. This is expected to contribute to market growth. The findings of the two surveys conducted in 2020 by the PFMA during the COVID-19 crisis confirmed a surge in pet ownership in the U.K. Around 3.2 million households or 11% of people brought home a pet since the start of the pandemic.

Increasing numbers of veterinary hospitals and clinics offering orthopedic surgeries for dogs are anticipated to propel the market growth. Sirius Veterinary Orthopedic Center in the U.S., for instance, is a referral-only small animal clinic specializing in orthopedic procedures. The clinic provides treatment for conditions including fractures, injuries, degeneration in the patella, meniscus, cranial cruciate ligament, hip dysplasia or luxation, joint infections, osteoarthritis, and other degenerative conditions. Veterinary Orthopedic and Surgical Care Center in the U.S. performs a range of veterinary surgeries. More than 1000 corrective osteotomies have been performed by the Center making ACL surgeries the most common at the facility.

Canine Orthopedics Market Report Highlights

• The rising prevalence and incidence of chronic diseases, sports injuries, and trauma in pet dogs is one of the key contributing factors to the market growth

• The implants segment held the largest revenue share of the market in 2024. This is due to the growing use of implants in orthopedic surgeries in canines

• BioMedtrix, for example, offers Cemented Fixation (CFX) and Biologic Fixation (BFX) Total Hip System for hip replacement surgeries in companion animals. Since the product’s launch, over 54,000 procedures have been performed globally, with about 95% of pet patients completely recovering

• The application segment was dominated by TPLO with a revenue share of 28.59% in 2024, on account of the growing use of TPLO implants and instruments in pet dogs

• Queensland Veterinary Specialists based in Australia offer multiple types of cruciate surgery such as TTA, TPLO, CBLO, Lateral suture, and TTO. However, they recommend TPLO over other techniques because of its published evidence relating to low infection rates, low late meniscal injury rates, and extremely rare implant-related issues.

• By end-use, the veterinary hospitals and clinics segment accounted for the largest revenue share of the global market in 2024.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Canine Orthopedics Market Summary, 2024
Chapter 3 Canine Orthopedics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping, 2024
3.3 Canine Orthopedics Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Canine Orthopedics Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Substitution Threat
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Canine Orthopedics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2 Current and Future Impact Analysis
4.3 Impact on Market Players
Chapter 5 Canine Orthopedics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Application Market Share Analysis, 2024 & 2030
5.2 Canine Orthopedics Market, by Application, 2018 to 2030
5.3 TPLO
5.3.1 TPLO market, 2018 - 2030 (USD Million)
5.4 TTA
5.4.1 TTA market, 2018 - 2030 (USD Million)
5.5 Joint Replacement
5.5.1 Joint Replacement Market, 2018 - 2030 (USD Million)
5.6 Trauma
5.6.1 Trauma market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Canine Orthopedics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
6.1 Product Market Share Analysis, 2024 & 2030
6.2 Canine Orthopedics Market, by Product, 2018 to 2030
6.3 Implants
6.3.1 Implants market, 2018 - 2030 (USD Million)
6.3.2 Plates
6.3.2.1 Plates market, 2018 - 2030 (USD Million)
6.3.2.2 TPLO Plates
6.3.2.2.1 TPLO Plates market, 2018 - 2030 (USD Million)
6.3.2.3 TTA Plates
6.3.2.3.1 TTA Plates market, 2018 - 2030 (USD Million)
6.3.2.4 Specialty Plates
6.3.2.4.1 Specialty Plates market, 2018 - 2030 (USD Million)
6.3.2.5 Trauma Plates
6.3.2.5.1 Trauma Plates market, 2018 - 2030 (USD Million)
6.3.2.6 Others
6.3.2.6.1 Others market, 2018 - 2030 (USD Million)
6.3.3 Others
6.3.3.1 Others market, 2018 - 2030 (USD Million)
6.4 Instruments
6.4.1 Instruments market, 2018 - 2030 (USD Million)
Chapter 7 Canine Orthopedics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1 End Use Market Share Analysis, 2024 & 2030
7.2 Canine Orthopedics Market, by End Use, 2018 to 2030
7.3 Hospitals & Clinics
7.3.1 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 8 Canine Orthopedics Market: Regional Market Analysis 2018 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Movement Analysis, 2024 & 2030
8.3 Regional Market Snapshot
8.4 North America
8.4.1 North America Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1 U.S. Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.4.4 Mexico
8.4.4.1 Mexico Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5 Europe
8.5.1 Europe Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.2 UK
8.5.2.1 UK Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.4 France
8.5.4.1 France Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.7 Denmark
8.5.7.1 Denmark Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.8 Sweden
8.5.8.1 Sweden Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.5.9 Norway
8.5.9.1 Norway Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6.2 Japan
8.6.2.1 Japan Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6.3 China
8.6.3.1 China Canine Orthopedics Market, 2018 - 2030 (USD million)
8.6.4 India
8.6.4.1 India Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6.5 Australia
8.6.5.1 Australia Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6.6 South Korea
8.6.6.1 South Korea Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.6.7 Thailand
8.6.7.1 Thailand Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.7 Latin America
8.7.1 Latin America Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.7.3 Argentina
8.7.3.1 Argentina Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.8 MEA
8.8.1 MEA Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.8.4 UAE
8.8.4.1 UAE Canine Orthopedics Market, 2018 - 2030 (USD Million)
8.8.5 Kuwait
8.8.5.1 Kuwait Canine Orthopedics Market, 2018 - 2030 (USD Million)
Chapter 9 Canine Orthopedics Market - Competitive Analysis
9.1 Market Participant Categorization
9.1.1. Company Market Position Analysis, heat map analysis
9.1.2. Synergy Analysis: Major Deals & Strategic Alliances
9.1.3. Market Leaders & Innovators
9.2. List of Key Companies
Chapter 10 Canine Orthopedics Market - Company Profiles
10.1 B. Braun SE
10.1.1 Company overview
10.1.2 FINANCIAL PERFORMANCE
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Movora (Vimian Group AB)
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Integra LifeSciences
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 DePuy Synthes (Johnson & Johnson)
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 AmerisourceBergen Corporation
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Arthrex, Inc.
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Orthomed (UK) Ltd.
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Veterinary Instrumentation
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Fusion Implants
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Narang Medical Limited
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives